Von Willebrand factor and factor VIII as potential biomarkers for diagnosis and disease monitoring in chronic graft-versus-host disease
Three simple blood clotting factors track graft-versus-host disease activity after bone marrow transplant, offering accessible markers doctors currently lack.
A prospective Croatian cohort study found that VWF antigen, VWF activity, and factor VIII are significantly elevated in active chronic graft-versus-host disease compared to post-HCT patients without cGvHD, with levels tracking disease activity longitudinally and demonstrating modest but clinically useful diagnostic accuracy (AUC ~0.73). These accessible biomarkers could complement current cGvHD monitoring tools which remain an unmet need in allogeneic HCT follow-up.
What the study was
- Study design
- Prospective cohort study
- Population
- 83 cGvHD patients vs. 39 allogeneic HCT recipients without cGvHD (UHC Zagreb)
- Sample size
- 122
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Bone Marrow Transplant
Why it surfaced
Prospective study with longitudinal tracking demonstrating VWF/FVIII as accessible cGvHD biomarkers. AUC ~0.73 is modest; external validation needed. Addresses genuine unmet diagnostic need in HCT.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.